ALEXANDRIA MCGOVERN: Open Payments
NPI 1083110753 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,444 in 166 payments from 17 companies in 2025. Trend: 2023 $2,229 · 2024 $3,056 · 2025 $3,444
Food & beverage: $3,338Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $490 |
| GENZYME CORPORATION | 11 | $326 |
| ABBVIE INC. | 33 | $318 |
| Incyte Corporation | 14 | $304 |
| Galderma Laboratories, L.P. | 26 | $254 |
| Organon LLC | 8 | $225 |
| PFIZER INC. | 1 | $200 |
| Novartis Pharmaceuticals Corporation | 8 | $182 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $178 |
| E.R. Squibb & Sons, L.L.C. | 11 | $176 |
Products named: TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, CIBINQO, Sotyktu, NEMLUVIO, OTEZLA.
Industry payments across MA — which companies pay providers there.
